These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 2863809

  • 1. Mesolimbic and striatal dopamine receptor supersensitivity: prophylactic and reversal effects of L-prolyl-L-leucyl-glycinamide (PLG).
    Chiu P, Rajakumar G, Chiu S, Johnson RL, Mishra RK.
    Peptides; 1985; 6(2):179-83. PubMed ID: 2863809
    [Abstract] [Full Text] [Related]

  • 2. Down-regulation of haloperidol-induced striatal dopamine receptor supersensitivity by active analogues of L-prolyl-L-leucyl-glycinamide (PLG).
    Rajakumar G, Naas F, Johnson RL, Chiu S, Yu KL, Mishra RK.
    Peptides; 1987; 8(5):855-61. PubMed ID: 2893360
    [Abstract] [Full Text] [Related]

  • 3. Neuroleptic drug-induced dopamine receptor supersensitivity: antagonism by L-prolyl-L-leucyl-glycinamide.
    Chiu S, Paulose CS, Mishra RK.
    Science; 1981 Dec 11; 214(4526):1261-2. PubMed ID: 6117947
    [Abstract] [Full Text] [Related]

  • 4. Modulation of CNS dopamine receptors by peptides.
    Mishra RK.
    Prog Neuropsychopharmacol Biol Psychiatry; 1983 Dec 11; 7(4-6):437-42. PubMed ID: 6141599
    [Abstract] [Full Text] [Related]

  • 5. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats.
    Bhargava HN.
    Neuropharmacology; 1984 Apr 11; 23(4):439-44. PubMed ID: 6145116
    [Abstract] [Full Text] [Related]

  • 6. Effect of L-prolyl-L-leucyl-glycinamide (PLG) on neuroleptic-induced catalepsy and dopamine/neuroleptic receptor bindings.
    Chiu S, Paulose CS, Mishra RK.
    Peptides; 1981 Apr 11; 2(1):105-11. PubMed ID: 6113579
    [Abstract] [Full Text] [Related]

  • 7. The use of striatal dopaminergic supersensitivity for the evaluation of drugs with possible antidyskinetic properties.
    Valchár M, Krejcí I, Kasafírek E, Schuh J, Dlabac A.
    Pol J Pharmacol Pharm; 1985 Apr 11; 37(3):311-5. PubMed ID: 2866500
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhanced striatal 3H-spiroperidol binding induced by chronic haloperidol treatment inhibited by peptides administered during the withdrawal phase.
    Bhargava HN.
    Life Sci; 1984 Feb 27; 34(9):873-9. PubMed ID: 6142397
    [Abstract] [Full Text] [Related]

  • 10. Attenuation of SCH 23390-induced alteration of striatal dopamine D1 receptor ontogeny by prolyl-leucyl-glycinamide in the rat.
    Kostrzewa RM, Saleh MI.
    Neuropharmacology; 1989 Aug 27; 28(8):805-10. PubMed ID: 2571103
    [Abstract] [Full Text] [Related]

  • 11. Differences in the time course of haloperidol-induced up-regulation of rat striatal and mesolimbic dopamine receptors.
    Prosser ES, Csernansky JG, Hollister LE.
    Life Sci; 1988 Aug 27; 43(8):715-20. PubMed ID: 2901023
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chronic nicotine use blocks haloperidol-induced increase in striatal D2-dopamine receptor density.
    Prasad C, Spahn SA, Ikegami H.
    Biochem Biophys Res Commun; 1989 Feb 28; 159(1):48-52. PubMed ID: 2522303
    [Abstract] [Full Text] [Related]

  • 15. Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.
    Prosser ES, Pruthi R, Csernansky JG.
    Psychopharmacology (Berl); 1989 Feb 28; 99(1):109-16. PubMed ID: 2506596
    [Abstract] [Full Text] [Related]

  • 16. MIF-I and postsynaptic receptor sites for dopamine.
    Kostrzewa RM, Hardin JC, Snell RL, Kastin AJ, Coy DH, Bymaster F.
    Brain Res Bull; 1979 Feb 28; 4(5):657-62. PubMed ID: 39665
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Striatal dopamine receptor supersensitivity after long-term haloperidol treatment of hypophysectomized rats.
    DeLucia R, Scavone C, Camillo MA.
    Braz J Med Biol Res; 1989 Feb 28; 22(6):741-3. PubMed ID: 2620186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.